The 1.6 A structure of Kunitz-type domain from the alpha 3 chain of human type VI collagen. 1995

B Arnoux, and K Mérigeau, and P Saludjian, and F Norris, and K Norris, and S Bjørn, and O Olsen, and L Petersen, and A Ducruix
Laboratoire de Biologie Structurale, CNRS, Gif sur Yvette, France.

The C-terminal Kunitz-type domain from the alpha 3 chain of human type VI collagen (C5), a single 58 amino acid residue chain with three disulfide bridges, was cloned, expressed and crystallized in a monoclonic form, space group P2(1), with a = 25.7 A, b = 38.2 A, c = 28.8 A and beta = 109 degrees. The structure was resolved by molecular replacement, using Alzheimer's protein precursor inhibitor and bovine pancreatic trypsin inhibitor three-dimensional structures as search models. The molecule with one sulfate ion and 43 associated water molecules was refined by XPLOR to an R-factor of 18.9% at 1.6 A. The molecule was not degraded by trypsin and did not inhibit trypsin or tested serine proteases. As opposed to the other Kunitz family members, C5 demonstrates left-handed chirality of the Cys14-Cys38 disulfide bond. Inversion of the Thr13 carbonyl and bulky side-chains at the interface with trypsin in a model of the C5-trypsin complex may explain the lack of inhibition of trypsin.

UI MeSH Term Description Entries
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

B Arnoux, and K Mérigeau, and P Saludjian, and F Norris, and K Norris, and S Bjørn, and O Olsen, and L Petersen, and A Ducruix
February 1996, Structure (London, England : 1993),
B Arnoux, and K Mérigeau, and P Saludjian, and F Norris, and K Norris, and S Bjørn, and O Olsen, and L Petersen, and A Ducruix
October 1994, European journal of biochemistry,
B Arnoux, and K Mérigeau, and P Saludjian, and F Norris, and K Norris, and S Bjørn, and O Olsen, and L Petersen, and A Ducruix
May 1998, Acta crystallographica. Section D, Biological crystallography,
B Arnoux, and K Mérigeau, and P Saludjian, and F Norris, and K Norris, and S Bjørn, and O Olsen, and L Petersen, and A Ducruix
August 1997, Biochemistry,
B Arnoux, and K Mérigeau, and P Saludjian, and F Norris, and K Norris, and S Bjørn, and O Olsen, and L Petersen, and A Ducruix
December 1996, Journal of biomolecular NMR,
B Arnoux, and K Mérigeau, and P Saludjian, and F Norris, and K Norris, and S Bjørn, and O Olsen, and L Petersen, and A Ducruix
July 2002, Acta crystallographica. Section D, Biological crystallography,
B Arnoux, and K Mérigeau, and P Saludjian, and F Norris, and K Norris, and S Bjørn, and O Olsen, and L Petersen, and A Ducruix
December 1989, The Journal of biological chemistry,
B Arnoux, and K Mérigeau, and P Saludjian, and F Norris, and K Norris, and S Bjørn, and O Olsen, and L Petersen, and A Ducruix
September 1996, Cornea,
B Arnoux, and K Mérigeau, and P Saludjian, and F Norris, and K Norris, and S Bjørn, and O Olsen, and L Petersen, and A Ducruix
June 1989, Matrix (Stuttgart, Germany),
B Arnoux, and K Mérigeau, and P Saludjian, and F Norris, and K Norris, and S Bjørn, and O Olsen, and L Petersen, and A Ducruix
February 1989, Nucleic acids research,
Copied contents to your clipboard!